Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05562921 · ClinicalTrials.gov registry record
Hypertension Management Using Remote Patient Monitoring
A clinical trial of Hypertension, sponsored by Northwestern University.
- Completed
- Registry status
- 1,440
- Enrollment target
- 1
- Study location
NCT05562921: Completed study of Hypertension, sponsored by Northwestern University.
NCT05562921 is a study of Hypertension that has completed, run by Northwestern University. The registered enrollment target is 1,440 participants, below the 3,504-participant average among 470 other Hypertension trials with a reported enrollment target (59% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05562921, a study of Hypertension, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- 1,440 participants
- Enrollment target
- 1
- Study location
Study Summary
A longer-term follow-up of patients with remote patient monitoring ordered from the initial six pilot primary care clinics (from the prior study periods: Study 1 and Study 2) will be performed and compared to a cohort of patients without RPM orders, matched on clinical and demographic characteristics, from the same six pilot primary care clinics, to serve as contemporary controls.
Primary Outcome
Proportion of patients who satisfy the performance measure Controlling High Blood Pressure (NQF 0018), last BP done within 1 year and is less than 140/90 mm Hg
Conditions Studied
Interventions
- BEHAVIORAL Controls-ususal care
- BEHAVIORAL Cases-remote patient monitoring prescribed
Study Locations (1)
Illinois
- Northwestern University - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,440 participants |
| Start Date | 2018-11-18 |
| Est. Completion | 2023-02-14 |
What the finished NCT05562921 record still lists
NCT05562921 is an observational study that tracks outcomes without assigning an intervention. Its 1,440 participants enrollment target places it among the larger protocols in the corpus, below the 3,504-participant average among 470 other Hypertension trials with a reported enrollment target (59% lower).
The record links to 1 condition, with Hypertension appearing as the primary indexed condition, and to 2 interventions - of which Controls-ususal care is the first listed.
NCT05562921 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT05562921 about?
NCT05562921 is a clinical study titled "Hypertension Management Using Remote Patient Monitoring". A longer-term follow-up of patients with remote patient monitoring ordered from the initial six pilot primary care clinics (from the prior study periods: Study 1 and Study 2) will be performed and compared to a cohort of patients without RPM orders, matched on clinical and demographic characteristic...
What is the current status of trial NCT05562921?
This trial is currently completed. The enrollment target is 1,440 participants. The study started on 2018-11-18. Estimated completion is 2023-02-14.
What conditions does trial NCT05562921 study?
This clinical trial studies the following conditions: Hypertension.
What interventions are being tested in trial NCT05562921?
The interventions under investigation include: Controls-ususal care (BEHAVIORAL), Cases-remote patient monitoring prescribed (BEHAVIORAL).
Who is sponsoring clinical trial NCT05562921?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05562921 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05562921's enrollment target sits among peer trials
1,440 46th of 470 higher than 425 of 470 other Hypertension trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
How a Mediterranean Diet With Potatoes Impacts Heart and Metabolic Health in Adults With Pre-Diabetes
RECRUITING · NA
-
Autonomic Regulation of Blood Pressure in Premature and Early Menopausal Women
RECRUITING
-
Conical Forearm and Cylindrical Upper Arm Non-Invasive Blood Pressure (NIBP) Measurements in Pregnant Patients
RECRUITING · NA
-
Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
RECRUITING · NA
-
Childhood-Onset Essential Hypertension Natural History Study
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04754022 · 1,440 participants · NA
Transfusion Requirements in Younger Patients Undergoing Cardiac Surgery
- NCT04989790 · 1,440 participants · NA
Clinical Effectiveness of the "PICU Up!" Multifaceted Early Mobility Intervention for Critically Ill Children
- NCT06122246 · 1,440 participants · NA
PRESSURE CHECK: Find Your Path to Better Health
- NCT06324318 · 1,440 participants · Phase 2
Parenting in 2 Worlds Multisite Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI